Clinical Trial Update: A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial [Phase 1, Phase 2]

View source ↗

Summary

A randomized, double-blind, placebo-controlled trial evaluating peanut sublingual immunotherapy in phase 1/2 has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Hypersensitivity
• Immediate Hypersensitivity
• Peanut Hypersensitivity

Drugs mentioned

• peanut sublingual immunotherapy

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Food Hypersensitivity, Hypersensitivity | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-10-30